Results for tag: "Enteric Disease Drug"

The Enteric Disease Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases of the digestive system. Enteric Disease Drugs are used to treat diseases of the small intestine, such as Crohn's Disease, Ulcerative Colitis, and Irritable Bowel Syndrome. These drugs are typically administered orally or rectally, and can include antibiotics, anti-inflammatory drugs, and immunosuppressants. Enteric Disease Drugs are designed to reduce inflammation, improve digestion, and reduce symptoms associated with the disease. Some companies in the Enteric Disease Drug market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Takeda. These companies produce a variety of Enteric Disease Drugs, including antibiotics, anti-inflammatory drugs, and immunosuppressants. Show Less Read more